Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Fortune Biotech Co., Ltd. is a leading biotechnology company specializing in the research, development, and large-scale production of Sodium Hyaluronate (Hyaluronic Acid). Founded in 2002 and based in Qufu, China, the company utilizes advanced microbial fermentation and purification technologies to produce various grades of HA for the global market. Their product portfolio includes pharmaceutical-grade HA used in ophthalmic surgery and intra-articular injections, as well as cosmetic and food-grade variants for skincare and nutraceuticals. Fortune Biotech is recognized for its high quality standards, maintaining certifications such as EU GMP, ISO 9001, and the Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines. The company serves as a critical supplier to major pharmaceutical and aesthetic companies worldwide, supporting applications in orthopedics, dermatology, and ophthalmology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fortune Biotech.